BR112017022941A2 - dispositivo de neuromodulação - Google Patents

dispositivo de neuromodulação

Info

Publication number
BR112017022941A2
BR112017022941A2 BR112017022941-2A BR112017022941A BR112017022941A2 BR 112017022941 A2 BR112017022941 A2 BR 112017022941A2 BR 112017022941 A BR112017022941 A BR 112017022941A BR 112017022941 A2 BR112017022941 A2 BR 112017022941A2
Authority
BR
Brazil
Prior art keywords
methods
treating
signal
neuromodulation device
provides
Prior art date
Application number
BR112017022941-2A
Other languages
English (en)
Portuguese (pt)
Inventor
John Chew Daniel
Jacob De Jonge Wouter
Jakob Kristoffer Famm Hans
Patel Sonal
Welting Olaf
Original Assignee
Galvani Bioelectronics Limited
Academisch Medisch Centrum
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galvani Bioelectronics Limited, Academisch Medisch Centrum filed Critical Galvani Bioelectronics Limited
Publication of BR112017022941A2 publication Critical patent/BR112017022941A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36007—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of urogenital or gastrointestinal organs, e.g. for incontinence control
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0551—Spinal or peripheral nerve electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0551—Spinal or peripheral nerve electrodes
    • A61N1/0556—Cuff electrodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36128—Control systems
    • A61N1/36135—Control systems using physiological parameters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112017022941-2A 2015-04-24 2016-04-22 dispositivo de neuromodulação BR112017022941A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562152119P 2015-04-24 2015-04-24
US62/152,119 2015-04-24
PCT/IB2016/052307 WO2016170510A1 (en) 2015-04-24 2016-04-22 Neuromodulation device

Publications (1)

Publication Number Publication Date
BR112017022941A2 true BR112017022941A2 (pt) 2018-07-17

Family

ID=55963419

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017022941-2A BR112017022941A2 (pt) 2015-04-24 2016-04-22 dispositivo de neuromodulação

Country Status (11)

Country Link
US (2) US10974041B2 (https=)
EP (2) EP3950049A1 (https=)
JP (1) JP2018514354A (https=)
KR (1) KR20180040516A (https=)
CN (1) CN108290041A (https=)
AU (1) AU2016252497A1 (https=)
BR (1) BR112017022941A2 (https=)
CA (1) CA2983652A1 (https=)
MA (1) MA41950A (https=)
RU (1) RU2017140776A (https=)
WO (1) WO2016170510A1 (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013134543A1 (en) 2012-03-08 2013-09-12 Medtronic Ardian Luxembourg Sarl Immune system neuromodulation and associated systems and methods
JP2017536187A (ja) 2014-12-03 2017-12-07 メタベンション インコーポレイテッド 神経または他の組織を調節するためのシステムおよび方法
US20180193643A1 (en) * 2015-06-05 2018-07-12 The Johns Hopkins University Method and device for sacral nerve stimulation
US10524859B2 (en) 2016-06-07 2020-01-07 Metavention, Inc. Therapeutic tissue modulation devices and methods
PT3481284T (pt) 2016-07-07 2021-10-14 Univ California Implantes utilizando retrodifusão ultrassónica para detetar sinais eletrofisiológicos
WO2019122904A1 (en) * 2017-12-20 2019-06-27 Galvani Bioelectronics Limited Treatment of inflammatory disorders
JP2021507762A (ja) 2017-12-20 2021-02-25 ガルバニ バイオエレクトロニクス リミテッド 急性疾患の治療
US11446502B2 (en) 2017-12-20 2022-09-20 Galvani Bioelectronics Limited Stimulation of a nerve supplying the spleen
JP2021507759A (ja) * 2017-12-20 2021-02-25 ガルバニ バイオエレクトロニクス リミテッド 炎症に関連する疾患の治療
WO2019122906A1 (en) 2017-12-20 2019-06-27 Galvani Bioelectronics Limited Treatment of acute medical conditions
CN112272575B (zh) 2018-04-19 2024-05-17 艾奧塔生物科技公司 使用用于神经感测和刺激的超声通信的植入物
AU2019255373B2 (en) 2018-04-19 2025-02-06 Iota Biosciences, Inc. Implants using ultrasonic communication for modulating splenic nerve activity
US10974079B2 (en) * 2018-08-29 2021-04-13 General Electric Company Neuromodulation techniques
CA3109810A1 (en) 2018-08-29 2020-03-05 Jose M. Carmena Implantable closed-loop neuromodulation device, systems, and methods of use
US12447343B2 (en) * 2018-12-20 2025-10-21 Galvani Bioelectronics Limited Neurostimulation device for blocking blood flow between electrodes
WO2020254798A1 (en) * 2019-06-19 2020-12-24 Galvani Bioelectronics Limited Stimulation of a nerve supplying the spleen
EP3986531A1 (en) * 2019-06-19 2022-04-27 Galvani Bioelectronics Limited Treatment of acute medical conditions
US20220305259A1 (en) * 2019-06-19 2022-09-29 Galvani Bioelectronics Limited System for the Treatment of Disorders Associated with Inflammation
CN114828945A (zh) 2019-10-17 2022-07-29 艾奧塔生物科技公司 用于调节癌症患者的免疫系统活性和治疗癌症的装置和方法
US12370383B2 (en) * 2020-04-09 2025-07-29 General Electric Company Neuromodulation to treat physiological conditions
WO2022122833A1 (en) * 2020-12-09 2022-06-16 Galvani Bioelectronics Limited Physiological effects of activation of the alox15 pathway
CN113197587A (zh) * 2021-04-26 2021-08-03 中国科学院深圳先进技术研究院 一种用于迷走神经刺激和电生理检测的装置及植入方法
WO2023017253A1 (en) * 2021-08-10 2023-02-16 Galvani Bioelectronics Limited Neuromodulation device
KR20230078121A (ko) * 2021-11-26 2023-06-02 주식회사 뉴라이브 동물용 미주신경 자극장치
CN114177472A (zh) * 2021-11-30 2022-03-15 中国人民解放军总医院第四医学中心 一种应用于下肢假肢的植入式电刺激感知反馈系统
US20250229086A1 (en) 2022-01-20 2025-07-17 Setpoint Medical Corporation Treatment of inflammatory disorders

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7389145B2 (en) 2001-02-20 2008-06-17 Case Western Reserve University Systems and methods for reversibly blocking nerve activity
US20060116736A1 (en) 2001-07-23 2006-06-01 Dilorenzo Daniel J Method, apparatus, and surgical technique for autonomic neuromodulation for the treatment of obesity
US7418292B2 (en) * 2003-10-01 2008-08-26 Medtronic, Inc. Device and method for attenuating an immune response
US20050075702A1 (en) * 2003-10-01 2005-04-07 Medtronic, Inc. Device and method for inhibiting release of pro-inflammatory mediator
US8214047B2 (en) * 2004-09-27 2012-07-03 Advanced Neuromodulation Systems, Inc. Method of using spinal cord stimulation to treat gastrointestinal and/or eating disorders or conditions
CN102793972A (zh) 2004-12-27 2012-11-28 范因斯坦医学研究院 通过电刺激迷走神经治疗炎症性疾病
AU2006315829B2 (en) * 2005-11-10 2011-01-27 ElectroCore, LLC. Electrical stimulation treatment of bronchial constriction
EP1984064A4 (en) * 2006-02-10 2009-11-11 Electrocore Inc METHODS AND APPARATUS USED TO TREAT ANAPHYLAXIS USING ELECTRICAL MODULATION
US9539425B2 (en) * 2006-10-13 2017-01-10 Intelect Medical, Inc. Systems and methods for treating medical conditions by stimulation of medial thalamic region
WO2008096730A1 (ja) * 2007-02-09 2008-08-14 National University Corporation Nagoya University 抗炎症剤及びその用途
US20090275997A1 (en) * 2008-05-01 2009-11-05 Michael Allen Faltys Vagus nerve stimulation electrodes and methods of use
CN106264720A (zh) * 2010-12-28 2017-01-04 西比姆公司 用于患者的交感再平衡的方法
EP2707094B1 (en) * 2011-05-09 2016-02-03 Setpoint Medical Corporation Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
CA2834180C (en) 2011-05-19 2019-04-30 Neuros Medical, Inc. High-frequency electrical nerve block
AU2012347470B2 (en) * 2011-12-09 2017-02-02 Medtronic Ireland Manufacturing Unlimited Company Therapeutic neuromodulation of the hepatic system
CN104145466A (zh) * 2012-02-24 2014-11-12 诺基亚公司 用于动态服务器/客户端控制的连通性逻辑的方法和装置
WO2013134541A2 (en) * 2012-03-08 2013-09-12 Medtronic Ardian Luxembourg Sarl Gastrointestinal neuromodulation and associated systems and methods
WO2014153223A1 (en) * 2013-03-14 2014-09-25 Perryman Laura Tyler Treating inflammation, chronic pain and other disorders with neuromodulation

Also Published As

Publication number Publication date
KR20180040516A (ko) 2018-04-20
CA2983652A1 (en) 2016-10-27
US20210393949A1 (en) 2021-12-23
MA41950A (fr) 2018-02-28
JP2018514354A (ja) 2018-06-07
EP3950049A1 (en) 2022-02-09
CN108290041A (zh) 2018-07-17
AU2016252497A1 (en) 2017-11-09
US20180117319A1 (en) 2018-05-03
WO2016170510A1 (en) 2016-10-27
US10974041B2 (en) 2021-04-13
EP3285856A1 (en) 2018-02-28
RU2017140776A (ru) 2019-05-24

Similar Documents

Publication Publication Date Title
BR112017022941A2 (pt) dispositivo de neuromodulação
IL273820B (en) Systems and methods for ensuring data security in the treatment of diseases and disorders using digital therapeutics
DK4218640T3 (en) Systems for the treatment of disease states and disorders
EP3758771A4 (en) LIQUID PREPARATION AND TREATMENT DEVICES, METHODS AND SYSTEMS
EP3405251A4 (en) SYSTEMS, METHODS AND DEVICES FOR PERIPHERAL NEUROMODULATION FOR THE TREATMENT OF DISEASES RELATED TO BUBBLE HYPERACTIVITY
MX383587B (es) Sistemas y métodos para el enlace neuronal del sistema nervioso.
EP3347085A4 (en) DEVICE FOR PERIPHERAL OR SPINAL STIMULATION
EP3271776A4 (en) Methods and systems for diagnosing and treating health ailments
EP3193711C0 (en) IMAGING DEVICE AND DATA MANAGEMENT SYSTEM FOR MEDICAL DEVICES
PL3865102T3 (pl) Urządzenie i sposób leczenia zaburzeń neurologicznych układu słuchowego
EP3500267A4 (en) NICOTINAMIDRIBOSIDE AND PTEROSTILLE COMPOSITIONS AND METHOD FOR TREATING NEURODEGENERATIVE DISEASES
FR3032353B1 (fr) Composition pharmaceutique et dispositif pour le traitement de la douleur
EP3307754A4 (en) NICOTINAMIDRIBOSIDE AND PTEROSTODY COMPOSITIONS AND METHOD FOR TREATING SKIN DISEASES
BR112018000707A2 (pt) ?composições terapêuticas e produto de combinação?
EP3831281C0 (en) Devices and systems for biomedical targeting and delivery
TWI560149B (en) Recovery apparatus for sewage treatment and sewage treatment system
TN2017000074A1 (en) Methyl-and trifluoromethyl-substituted pyrrolopyridine modulators of rorc2 and methods of use thereof
CL2016001076A1 (es) (aza) piridopirazolopirimidinonas e indazolopirimidinonas como inhibidores de fibrinolosis.
SMT202100373T1 (it) Metodi e composizioni per la stimolazione del sistema enteroendocrino intestinale per il trattamento di malattie o condizioni correlate allo stesso
EP3630271C0 (en) APPARATUS FOR DELIVERING PAIN RELIEF TREATMENT
EP3577382A4 (en) SYSTEM AND APPARATUS FOR COMPRESSION DUCT RETAINING ELEMENT
PH12019500422A1 (en) Methods and composition for the prediction of the activity of enzastaurin
GB201804417D0 (en) Method and system for diagnosing disease and generating treatment recommendations
EP3166477A4 (en) Systems and methods for diagnosis and treatment of swallowing disorders
EP3536670A4 (en) Electrolytic treatment device and treatment system

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]